Mankind Pharma Ltd Share Price – NSE  / BSE

Pharmaceuticals, Mid Cap

Mankind Pharma has allotted 46,582 equity shares under ESOP on 26 November 2025. With this allotment, the paid up equity share capital has increased to 41,28,05,072 equity shares having face value of Re 1/- each.

Powered by Capital Market - Live News

Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2222.3, down 0.64% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.14% on the day, quoting at 25609.05. The Sensex is at 83614.62, up 0.09%.Mankind Pharma Ltd has eased around 9.02% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has increased around 0.57% in last one month and is currently quoting at 22379.85, down 0.22% on the day. The volume in the stock stood at 2.28 lakh shares today, compared to the daily average of 3.64 lakh shares in last one month.

The benchmark November futures contract for the stock is quoting at Rs 2231.5, down 0.72% on the day. Mankind Pharma Ltd tumbled 15.25% in last one year as compared to a 7.23% rally in NIFTY and a 0.81% spurt in the Nifty Pharma index.

The PE of the stock is 55.39 based on TTM earnings ending September 25.

Powered by Capital Market - Live News

Net profit of Mankind Pharma declined 21.72% to Rs 511.51 crore in the quarter ended September 2025 as against Rs 653.47 crore during the previous quarter ended September 2024. Sales rose 20.77% to Rs 3697.16 crore in the quarter ended September 2025 as against Rs 3061.43 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News

Mankind Pharma has received reaffirmation in credit ratings from CRISIL at CRISIL AA+/ Stable / CRISIL A1+.

Powered by Capital Market - Live News